Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kay

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 9, 2008
Orthotopic heart transplantation in a patient with corrected L-transposition of great arteries and dextrocardiaAlfred J Tector, Michael Savitt, C Jennifer Dankle, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patientsHani H Abujudeh, Hillary Rolls, Rathachai Kaewlai, et al.
Annals of the Rheumatic Diseases|July 31, 2013
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER studyJosef S Smolen, Jonathan Kay, Eric L Matteson, et al.
Plos One|May 24, 2021
Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative studyKate L Lapane, Divya Shridharmurthy, Sara Khan, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.
The American Journal of Dermatopathology|October 12, 2012
Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosisLong P Le, Lilit Garibyan, Daniel Lara, et al.
Arthritis Research & Therapy|February 4, 2014
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one yearJonathan Kay, Olga Morgacheva, Susan P Messing, et al.
Malaria Journal|August 30, 2019
Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern BelizeStaci M Dreyer, Donovan Leiva, Marla Magaña, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 9, 2008
Orthotopic heart transplantation in a patient with corrected L-transposition of great arteries and dextrocardiaAlfred J Tector, Michael Savitt, C Jennifer Dankle, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patientsHani H Abujudeh, Hillary Rolls, Rathachai Kaewlai, et al.
Annals of the Rheumatic Diseases|July 31, 2013
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER studyJosef S Smolen, Jonathan Kay, Eric L Matteson, et al.
Plos One|May 24, 2021
Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative studyKate L Lapane, Divya Shridharmurthy, Sara Khan, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
The Journal of Rheumatology|June 3, 2009
E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapySudha Visvanathan, Carrie Wagner, Jeannie Rojas, et al.
The American Journal of Dermatopathology|October 12, 2012
Fibrosis-associated single-nucleotide polymorphisms in TGFB1 and CAV1 are not associated with the development of nephrogenic systemic fibrosisLong P Le, Lilit Garibyan, Daniel Lara, et al.
Arthritis Research & Therapy|February 4, 2014
Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one yearJonathan Kay, Olga Morgacheva, Susan P Messing, et al.
Malaria Journal|August 30, 2019
Fipronil and ivermectin treatment of cattle reduced the survival and ovarian development of field-collected Anopheles albimanus in a pilot trial conducted in northern BelizeStaci M Dreyer, Donovan Leiva, Marla Magaña, et al.
Pageof 18